Aphasia, Primary Progressive: Clinical Trials

84 trials for Aphasia, Primary Progressive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 26 recruiting, 5 active not recruiting, 5 terminated. 51 Not applicable, 8 Phase 2, 6 Phase 1, 3 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable51Completed 23, Recruiting 12, Enrolling by invitation 4, Withdrawn 4, Active not recruiting 3, Terminated 3, Unknown 2
Phase 28Completed 3, Recruiting 3, Active not recruiting 1, Terminated 1
Phase 16Completed 3, Recruiting 1, Terminated 1, Unknown 1
Early Phase 13Recruiting 2, Completed 1
Phase 41Recruiting 1

Follow Aphasia, Primary Progressive: new trials by email Literature Review of Aphasia, Primary Progressive trials Research Report on Aphasia, Primary Progressive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stimulating the Aging Brain Using Brain and Sensory Stimulation
tACS or multisensory stimulation - Primary Progressive Aphasia
Not applicableRecruitingMedical College of Wisconsin202026-06-012026-06-16
Targeted Transcranial Magnetic Stimulation to Improve Language and Speech in Patients With Primary Progressive Aphasia
Training with Speech Language Therapy, Standard rTMS, Targeted rTMS - Primary Progressive Aphasia(PPA)
Not applicableEnrolling by invitationIRCCS San Raffaele752026-05-132026-05-20
Remotely-supervised Neuromodulation in PPA
Lexical Retrieval Cascade Treatment, Remotely Supervised Transcranial Direct Current Stimulation- Active, Remotely Supervised Transcranial Direct Current Stimulation - Sham - Primary Progressive Aphasia(PPA), Progressive Aphasia
Not applicableRecruitingMaya Henry802026-04-152026-09-04
Intervention for Communication Quality of Life in Primary Progressive Aphasia
Multicomponent Lexical Retrieval Cascade Training, Multicomponent Video Implemented Script Training in Aphasia - Primary Progressive Aphasia(PPA), Semantic Dementia
Not applicableRecruitingMaya Henry302026-04-012026-04-21
Biofluid Research on Age-Related or Inherited Neurodegeneration
Frontotemporal Degeneration (FTD), ALS (Amyotrophic Lateral Sclerosis)
RecruitingUniversity of Pennsylvania10002025-12-122026-09-01
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
Neflamapimod, Placebo - Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
Phase 2Active not recruitingEIP Pharma Inc202025-10-022026-07-06
Long Term Effect of Brain Stimulation in PPA
TMS, tDCS, Sham TMS - Primary Progressive Aphasia(PPA)
Not applicableRecruitingHospital San Carlos, Madrid802025-09-152026-04-23
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
STELLA-FTD Control, STELLA-FTD Test - Frontotemporal Dementia, Caregiver Burden
Not applicableRecruitingOregon Health and Science University6402025-06-232025-10-27
Propranolol in Primary Progressive Aphasia
Propranolol, Magnetic Resonance Imaging (MRI), Placebo - Aphasia, Primary Progressive
Early Phase 1RecruitingUniversity of Missouri-Columbia302025-01-132026-07-17
Predict to Prevent PGRN Disease
Clinical, behavioral and cognitive evaluation, blood sampling, brain MRI - Frontotemporal Dementia (FTD), GRN Related Frontotemporal Dementia
Not applicableWithdrawnAssistance Publique - Hôpitaux de Paris2025-01-012025-03-21
Effects of Transcranial Direct Current Stimulation (tDCS) on Inhibition and Brain Function in Primary Progressive Aphasia
tDCS, SHAM - Aphasia, Primary Progressive
Not applicableRecruitingCentre Hospitalier Universitaire de Nice202024-11-042024-11-05
Speech and Language Interventions for Italian People With PPA
Behavioral Treatment - Primary Progressive Aphasia(PPA)
RecruitingIstituti Clinici Scientifici Maugeri SpA302024-09-012026-10-26
Communication Bridge 3 Study
Communication Bridge™, Evidence-Based Impairment Focused - Primary Progressive Aphasia
Phase 2RecruitingUniversity of Chicago2002024-08-232026-06-01
Communication Bridge Pilot Study
Communication Bridge - Primary Progressive Aphasia
Not applicableActive not recruitingUniversity of Chicago122024-06-282025-08-07
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
Psychosocial educational, support group and implementation of strategies - Alzheimer Disease, Dementia
Early Phase 1RecruitingUniversity of Texas at Austin1202024-05-212026-06-10
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Active tDCS + Language Therapy, Sham tDCS + Language Therapy - Primary Progressive Aphasia, Logopenic Progressive Aphasia
Phase 2RecruitingJohns Hopkins University1802024-02-132026-05-05
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
Dementia, Alzheimer Disease
RecruitingUniversity Health Network, Toronto5002023-11-112025-11-20
Transmagnetic Stimulation Pilot in Primary Progressive Aphasia
Intermittent theta burst stimulation - Primary Progressive Aphasia
Not applicableCompletedHealthPartners Institute32023-10-022025-06-03
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101 - Frontotemporal Dementia, FTD
Phase 1 / Phase 2RecruitingAviadoBio Ltd182023-08-302026-08-13
Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease
Computerized Cognitive Training, Active tDCS (tDCS) on DLPFC - Mild Cognitive Impairment, Primary Progressive Aphasia
Not applicableTerminatedJohns Hopkins University52023-08-102026-10-21

Showing 20 of 84. Sign in to see all of them.

Narrower conditions

Frontotemporal Dementia (34)  ·  Alzheimer Disease (25)  ·  Aphasia (23)  ·  Primary Progressive Nonfluent Aphasia (20)  ·  Dementia (18)  ·  Corticobasal Degeneration (11)  ·  Neurodegenerative Diseases (11)  ·  Supranuclear Palsy, Progressive (11)  ·  Frontotemporal Lobar Degeneration (9)  ·  Apraxias (8)  ·  Pick Disease of the Brain (8)  ·  Amyotrophic Lateral Sclerosis (7)  ·  Neurocognitive Disorders (7)  ·  Cognitive Dysfunction (6)

Broader conditions

Pathological Conditions, Signs and Symptoms (84)  ·  Signs and Symptoms (84)  ·  Neurobehavioral Manifestations (83)  ·  Neurologic Manifestations (83)  ·  Central Nervous System Diseases (82)  ·  Mental Disorders (82)  ·  Nervous System Diseases (82)  ·  Brain Diseases (81)  ·  Language Disorders (79)  ·  Speech Disorders (79)  ·  Communication Disorders (78)  ·  Neurocognitive Disorders (77)  ·  Dementia (66)  ·  Aphasia (61)  ·  Nutritional and Metabolic Diseases (45)

Interventions

Transcranial Direct Current Stimulation (8)  ·  Speech Therapy (6)  ·  Language Therapy (5)  ·  Transcranial Magnetic Stimulation (3)  ·  Blood Specimen Collection (2)  ·  Therapeutics (2)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (1)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)  ·  AADvac1 (1)  ·  Behavior Therapy (1)  ·  Exercise (1)  ·  Genetic Testing (1)  ·  Magnetic Resonance Imaging (1)  ·  Observation (1)

Sponsors

Johns Hopkins University (7)  ·  University of Chicago (7)  ·  University of Pennsylvania (5)  ·  Mayo Clinic (4)  ·  University of California, San Francisco (4)  ·  University of Texas at Austin (4)  ·  Hospital San Carlos, Madrid (3)  ·  Baycrest (2)  ·  IRCCS Centro San Giovanni di Dio Fatebenefratelli (2)  ·  IRCCS San Raffaele (2)  ·  Maya Henry (2)  ·  Medical College of Wisconsin (2)  ·  Northwestern University (2)  ·  Peking Union Medical College Hospital (2)  ·  University Health Network, Toronto (2)

Countries

United States (53)  ·  Canada (13)  ·  Italy (7)  ·  Spain (5)  ·  United Kingdom (4)  ·  France (3)  ·  Netherlands (2)  ·  Sweden (2)  ·  Belgium (1)  ·  China (1)  ·  Germany (1)  ·  Poland (1)

Top investigators

Kyrana Tsapkini, PhD (4)  ·  Maya L Henry, PhD (4)  ·  Aneta Kielar, PhD (2)  ·  Emily Rogalski, Ph.D (2)  ·  Emily Roglaski, PhD (2)  ·  Maria C Tartaglia, M.D. (2)  ·  Aaron Meyer, PhD (1)  ·  Adam Boxer, MD, PhD (1)  ·  Adam L Boxer, MD, PhD (1)  ·  Adam L. Boxer, M.D., Ph.D. (1)  ·  Aimee Mooney, MA, CCC-SLP (1)  ·  Alessandro Martorana, MD, PhD (1)  ·  Allan Young, Professor (1)  ·  Allison Lindauer, PhD, APRN (1)  ·  Argye E Hillis, MD, MA (1)

Results publications

PMID 33441454, PMID 28713256, PMID 30258975, PMID 33031971, PMID 33827960, PMID 34006157, PMID 34487043, PMID 34489348, PMID 34875098, PMID 34937781, PMID 35492244, PMID 35667724, PMID 35698099, PMID 35790423, PMID 36662282, PMID 37287321, PMID 37508992, PMID 37821924, PMID 37838080, PMID 37955923, PMID 38807183, PMID 40070907, PMID 40754329, PMID 40788648, PMID 40809903, PMID 40857539, PMID 41041680, PMID 41812391, PMID 41864233, PMID 42161537, PMID 42818139

NIH funding

R01AG055425 (4), P01AG066597 (2), 1RF1AG050967-01A1 (1), 2017 (1), 2023 (1), F31DC020352 (1), P30AG072979 (1), R01AG054519 (1), R01AG075111 (1), R01AG075404 (1), R01AG077444 (1), R01AG084523 (1), R01DC007683 (1), R01DC012519 (1), R01DC014475 (1)